VC  Venture Investors

http://www.ventureinvestors.com





     Office Locations:

201 South Main Street, Suite 900
Ann Arbor, MI 48104
Phone: 734-274-2904
Fax: 734-214-3006

Get all office locations for this firm with a National Database subscription.
 

Stages:

  • Early
  • Seed


 

Industries:

  • Energy & Clean Tech
  • Information Technology
  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Since 1982, Venture Investors has been providing seed and early stage venture capital to technology based companies in the Midwest. The firm focuses on Healthcare (including Biotechnology and Medical Devices), Clean Tech, and Information Technology. Its investment level ranges from a small seed round to $7.5 million over time. Venture Investors is currently investing out of its fifth fund and has over $200 million under management. Venture Investors considers seed rounds starting at $50,000 up to $8.0M over time. The firm has backed 19 companies that have been founded to commercialize innovations licensed from leading research institutions throughout the Midwest.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    David Arnstein CFO
    George Arida Advisor
    Jim Adox Managing Director
    John Neis Executive Managing Director
    Paul Weiss Managing Director

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      11/09/2018


      Eximis Surgical


      CO


      $7,500,000


      


      08/01/2018


      HealthMyne


      WI


      $15,000,000


      Series B


      01/11/2018


      Skyspecs


      MI


      $8,000,000


      Series B


     

    Portfolio companies include:


      Aerpio Therapeutics
        web link


      Akebia
        web link


      Akebia Therapeutics
        web link


      AlfaLight
        web link


      Celleration
        web link


      Chromatin
        web link


      Deltanoid Pharmaceuticals
        web link


      Euthymics Bioscience
        web link


      Eximis Surgical
        web link


      FluGen
        web link


      Gala Biotech
        web link


      GUILD
        web link


      HealthMyne
        web link


      HistoSonics
        web link


      Intralase
        web link


      Inviragen
        web link


      Juventas Therapeutics
        web link


      LenSx
        web link


      Madison Vaccines
        web link


      Mithridion
        web link


      NanoBio
        web link


      Nerites
        web link


      NetSocket
        web link


      Neurovance
        web link


      NeuWave Medical
        web link


      Novelos
        web link


      Pattern Insight
        web link


      Procertus
        web link


      Promega
        web link


      Reshape Medical
        web link


      Silatronix
        web link


      Skyspecs
        web link


      SoftSwitching Technologies
        web link


      TAI Diagnostics


      Tissue Regeneration Systems
        web link


      Virent Energy Systems
        web link


      ZyStor Therapeutics
        web link


     

    Recent News:


      There is no recent news for Venture Investors.